Key Insights into the COVID-19 Current Therapy Market: Trends, Growth Rate, and Opportunities Through 2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theCOVID-19 Current Therapy Market?
The COVID-19 pandemic has significantly caused the COVID-19 current therapy market to flourish. The World Health Organization (WHO) classified the outbreak as a worldwide pandemic. For instance, WHO, a specialized division of the United Nations based in Switzerland, reported that global COVID-19 cases surged to 581.8 million in August 2022. As there is no officially endorsed medication for COVID-19, repositioned drugs used for coronatherapy have seen a substantial increase in demand. Various countries globally are grappling with drug shortages, and pharmaceutical manufacturers are intensifying their production processes to cater to this increased worldwide demand. The US FDA initiated the COVID-19 Treatment Acceleration Program (CTAP) to expedite the creation of possible COVID-19 treatments, ensuring their swift availability to patients.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp
#How Will the CAGR of the COVID-19 Current Therapy Market Influence Its Overall Growth by 2034?
The market size for therapies treating COVID-19 has seen a dramatic fall in the past few years. The market is projected to plummet from “$5.87 billion in 2024 to $2.35 billion in 2025”, this inequivalent to an annual growth rate (CAGR) of -60.0%. The drop in the previous years can be accredited to factors such as the scarcity of treatment alternatives, inconsistent treatment effectiveness, interruptions in the supply chain, swift progress in scientific understanding, and the surfacing of new variants.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3247
What Are the Current Market Growth and Trends in theCOVID-19 Current Therapy Market That Industry Players Should Watch?
Convalescent Plasma Therapy (CPT) is an investigational treatment presently utilized for COVID-19 patients. Essentially, the blood plasma obtained from patients who have fully recovered from a disease is referred to as Convalescent Plasma (CP). This CP therapy, a form of passive antibody treatment, involves the extraction and administration of blood plasma from recovered patients to those with severe symptoms, to reduce virulence and enhance clinical outcomes. It rests on the idea that the blood plasma from patients who have recovered from COVID-19 possesses antibodies to combat the COVID-19 virus. Based on guidelines provided by the FDA, Convalescent Plasma Therapy is promoted as an investigational product in times of public health crises. As per the data, around 2,004 sites have registered for the single expanded access protocol by the US FDA. These sites have documented about 7,774 patients, and 3,809 have already received the convalescent plasma transfusion. If the data gathered sufficiently backs the results, experimental convalescent plasma therapy may gain increased focus.
What Are the Major Market Players Making an Impact on theCOVID-19 Current Therapy Market Growth?
Major companies operating in the COVID-19 current therapy market include Gilead Sciences, Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals, Inc., Mylab Discovery Solutions, Kalbe Farma, He Qi Group Foundation, Beijing Jinwofu Bioengineering Technology Company, Zhejiang Orient Gene Biotech Co. Ltd, Transasia Bio Medicals, Vanguard Diagnostics, HLL Lifecare Limited, Voxtur Bio Ltd, Biocryst Pharma, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc., LAB-CARE Diagnostics, ImmunoScience, CPC Diagnostics, Sysmex Corporation, Atomo Diagnostics, Cellmid Limited, Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Hunan Lituo Biotechnology, Hangzhou Biotest Biotech, AmonMed Biotechnology, Getein Biotech, Beijing Tigsun Diagnostics, Vivacheck Lab, Seegene, SD Biosensor, Fujirebio, Siemens Healthcare Pte. Ltd., Senova, LetsGetChecked, Omega Diagnostics, Abingdon Health, Babylon, Motologic, F. Hoffmann-La Roche Ltd., Novacyt Group, AstraZeneca, Pfizer, Zentiva, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi, Amgen and AdaptiveBiotechnologies, BioNtech, Cytodyn, Heat biologics, Johnson&Johnson, Takeda pharmaceuticals, Vaxart, Vir Biotechnology, Victory Square Health, Abbott Molecular Inc., ACRO Biotech, Advagen Biotech Ltd, BD, Boditech Med, Inc., Cellex Inc., CerTest Biotec, S.L., Hi Technologies, BATM, BioMedomics Quant Lease, CapeBio, Astel Diagnostics, Canary Health Technologies, Thermo Fisher Scientific
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report
How Are the Key Segments of the COVID-19 Current Therapy Market Driving Opportunities and Innovations?
The COVID-19 current therapy market covered in this report is segmented –
1) By Drug Type: Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs, Others
2) By Route Of Administration: Oral, Intravenous
3) By End-User: Hospitals, Clinics, Home Care, Others
Subsegments:
1) By Antiviral: Remdesivir, Oseltamivir, Favipiravir, Nirmatrelvir Or ritonavir (Paxlovid)
2) By Monoclonal Antibodies: Bamlanivimab, Casirivimab Or Imdevimab (REGEN-COV), Sotrovimab, Etesevimab
3) By Corticosteroid: Dexamethasone, Hydrocortisone, Prednisone
4) By Supplements: Vitamin D, Vitamin C, Zinc, Quercetin
5) By Antimalarial: Hydroxychloroquine, Chloroquine
6) By Interferons and Interleukin Inhibitors: Interferon beta-1a, Interleukin-6 inhibitors
7) By Other Anti-Infective Drugs: Antibiotics, Antifungal agents
8) By Others: Other experimental therapies, Alternative treatments not categorized above
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3247&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theCOVID-19 Current Therapy Market?# Market Expansion?
North America is the largest region in the COVID-19 current therapy market in 2024. Middle East is expected to be the fastest-growing region in the global COVID-19 current therapy market share during the forecast period. The regions covered in the COVID-19 current therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global COVID-19 Current Therapy Market 2025, By The Business Research Company:
COVID-19 Detection Test Kits and Consumables Global Market Report 2024
Hydroxychloroquine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report
Biologics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biologics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
